Follow The Filings

TBPH Theravance Biopharma

Theravance Biopharma earnings

No earnings events stored for TBPH yet. The name is tracked in the universe; consensus prints appear when the provider has them.

Insider trades

Open-market buys and sales by TBPH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TBPH insider trades
  • None no insider bought on the open market
  • $5.9M sold by 1 insider outside a trading plan
  • $2.1M sold by 2 insiders under 10b5-1 plans
  1. Rhonda Farnum SVP, Comm & Medical Affairs
    Planned sale
    $227K 13,314 shares at $17.03 5.9% of stake
    Traded Sep 15 Filed Sep 17
  2. Eli Samaha 10% owner
    Sale
    $119K 6,964 shares at $17.14 0.1% of stake
    Traded Jul 6–7 Filed Jul 8
  3. Eli Samaha 10% owner
    Sale
    $5.8M 336,697 shares at $17.20 3.5% of stake
    Traded Jun 29–Jul 1 Filed Jul 1
  4. Rhonda Farnum SVP, Comm & Medical Affairs
    Planned sale
    $218K 13,314 shares at $16.39 5.4% of stake
    Traded Jun 15 Filed Jun 17
  5. Rhonda Farnum SVP, Comm & Medical Affairs
    Planned sale
    $434K 31,067 shares at $13.96 12% of stake
    Traded Mar 16 Filed Mar 18
  6. Rhonda Farnum SVP, Comm & Medical Affairs
    Planned sale
    $583K 31,067 shares at $18.75 10% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  7. Eran Broshy Director
    Planned sale
    $590K 29,501 shares at $20.00 40% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
  8. Eran Broshy Director
    Planned sale
    $809K 45,000 shares at $17.98 43% of stake
    Traded Nov 11, 2025 Filed Nov 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 25 sales back to the company, 15 share withholdings for taxes, 10 stock grants, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
8-K 1.01,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
8-K 5.07
8-K 8.01
8-K 8.01,9.01
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,7.01,8.01,9.01
DEFA14A
8-K 5.02

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf